Good news! A new edition of the Young Researchers Meeting is here!
This year we celebrate the VII edition that will take place on 19th–20th November 2025 at the IIB - Instituto de Investigaciones Biomédicas Sols-Morreale (Madrid).
This meeting will serve as a platform for young and senior scientists to share their projects, and advancements in the field’s cancer.
Young researchers, through oral presentations and posters, and renowned experts, through presentations and round tables, will talk to us about different topics such as:
- Tumor Metabolism
- Tumor Microenvironment and Stromal Interactions
- Targeted Therapies and Resistance Mechanisms in Cancer
- Cancer Genomics, Epigenetics and Personalized Medicine
- Early Cancer Detection and Emerging Technologies
Online registration is open until 31st October.
The Organizing Committee
Mireia Ramos Muntada graduated in Genetics (UAB), then she completed a master’s degree in Cytogenetics and Reproductive Biology and obtained her PhD in Cellular Biology at the same university focused on rare diseases. She had her first contact with NGS during her PhD and subsequently followed this path as an NGS analyst. In 2021 she joined the Hereditary Cancer Program at the ICO-IDIBELL as Postdoctoral Researcher.
Marta Cano Galietero graduated in Biotechnology from the University of Murcia and completed a master’s degree in Translational Biomedical Research at the Autonomous University of Barcelona (UAB) and the Vall d'Hebron Institute of Research (VHIR). Since 2020, she has been part of the Translational Molecular Pathology group at VHIR. She is currently a fourth-year PhD student in the Biochemistry, Molecular Biology and Biomedicine program at the UAB. The aim of her thesis is to study the role of the MNK kinases in the tumor microenvironment.
Mikel Pujana studied Biochemistry and Molecular Biology at the University of the Basque Country, where he developed an interest in cancer research. He completed his undergraduate thesis at CIC bioGUNE and later pursued a Master’s in Biomedicine at the University of Barcelona. In 2019, he returned to CIC bioGUNE to begin his PhD, focusing on the role of polyamines in cancer. He successfully defended his thesis in 2023. Now, he is currently continuing his scientific career as a postdoctoral researcher under a CIBER-funded contract. His work centers on the study of metabolism in cancer.
Cristina Martínez Valiente studied Biotechnology at the Polytechnic University of Valencia. She then obtained a Master’s degree in Research in Molecular, Cellular, and Genetic Biology from the University of Valencia. In 2017, she joined the Hematology Research Group at La Fe Health Research Institute (IISLaFe). Five years later, she earned her PhD in Biotechnology, focusing on the study of a Myelodysplastic Syndrome mouse model. Since then, she has continued as a postdoctoral researcher in the same group, concentrating her work on myeloid neoplasms with germline predisposition
Ester Munera graduated in Biology from the University of Valencia and furthered her specialization with a Master's in Biomedical Biotechnology at the Polytechnic University of Valencia. She later earned her PhD in Molecular Biosciences from the Autonomous University of Madrid, completing her doctoral thesis at CIEMAT on animal models of bladder cancer and epigenetics. Currently, she is part of the Molecular Oncology Laboratory at the Foundation for Research of the University General Hospital of Valencia (FIHGUV), where she focuses on identifying biomarkers for immunotherapy response and developing lung cancer organoid models. Her research aims to bridge the gap between basic science and clinical application, with the goal of improving therapeutic strategies for cancer patients.
Pablo Ovejero graduated in Biotechnology from Universidad Francisco de Vitoria (UFV) and later completed a Master’s degree in Regenerative Medicine and Advanced Therapies at Universidad CEU San Pablo. Through the Cancer Immunotherapy and Immunology Program (CAIMI), a joint initiative by the Vall d’Hebron Institute of Oncology (VHIO) and BBVA Foundation, he carried out his master’s thesis at the Growth Factors Group. Following this experience, he joined the same group to pursue a PhD in Biomedicine at Universitat Pompeu Fabra, where he is currently in his second year. In parallel, he completed a Master’s degree in Bioinformatics at Universidad Internacional de Valencia (VIU). His research focuses on the transcriptional regulation of cancer-related genes.
